🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/05/2022 | 90,79 | 92,87 | 90,68 | 92,32 | +2,11% | 2,41% | 13.999.000 |
| 13/05/2022 | 90,70 | 91,05 | 89,26 | 90,41 | -0,46% | 1,97% | 10.308.100 |
| 12/05/2022 | 89,85 | 90,85 | 88,36 | 90,83 | +1,84% | 2,77% | 14.210.200 |
| 11/05/2022 | 87,42 | 90,81 | 87,42 | 89,19 | +1,57% | 3,88% | 16.338.600 |
| 10/05/2022 | 88,12 | 89,29 | 87,27 | 87,81 | +0,19% | 2,29% | 12.370.800 |
| 09/05/2022 | 87,50 | 88,06 | 86,91 | 87,64 | -0,85% | 1,31% | 11.901.500 |
| 06/05/2022 | 87,74 | 88,92 | 87,48 | 88,39 | +0,43% | 1,64% | 12.227.400 |
| 05/05/2022 | 88,42 | 88,66 | 87,03 | 88,01 | -0,58% | 1,84% | 9.548.300 |
| 04/05/2022 | 86,57 | 88,77 | 86,36 | 88,52 | +1,63% | 2,78% | 10.763.500 |
| 03/05/2022 | 86,99 | 88,24 | 86,43 | 87,10 | -0,63% | 2,08% | 8.425.600 |
| 02/05/2022 | 88,72 | 88,84 | 86,63 | 87,65 | -1,17% | 2,49% | 12.124.900 |
| 29/04/2022 | 88,66 | 90,01 | 88,09 | 88,69 | +0,12% | 2,17% | 15.914.200 |
| 28/04/2022 | 85,75 | 89,37 | 85,00 | 88,58 | +4,94% | 5,10% | 21.092.300 |
| 27/04/2022 | 84,30 | 85,13 | 83,60 | 84,41 | -0,08% | 1,81% | 10.781.300 |
| 26/04/2022 | 85,76 | 86,20 | 84,39 | 84,48 | -1,12% | 2,11% | 9.009.600 |
| 25/04/2022 | 84,59 | 85,81 | 83,53 | 85,44 | +1,00% | 2,70% | 10.573.400 |
| 22/04/2022 | 85,86 | 86,14 | 84,50 | 84,59 | -1,90% | 1,91% | 7.914.000 |
| 21/04/2022 | 86,41 | 87,23 | 85,39 | 86,23 | -0,27% | 2,13% | 8.562.400 |
| 20/04/2022 | 85,52 | 86,82 | 85,48 | 86,46 | +0,78% | 1,57% | 8.719.400 |
| 19/04/2022 | 85,97 | 86,09 | 85,12 | 85,79 | -0,33% | 1,13% | 8.494.700 |
| 18/04/2022 | 86,42 | 87,45 | 85,68 | 86,07 | -0,97% | 2,05% | 7.995.100 |
| 14/04/2022 | 86,13 | 87,51 | 85,41 | 86,91 | +0,91% | 2,44% | 22.096.100 |
| 13/04/2022 | 85,80 | 86,24 | 84,83 | 86,13 | +0,58% | 1,64% | 12.743.800 |
| 12/04/2022 | 86,00 | 86,55 | 85,22 | 85,63 | -1,15% | 1,55% | 12.543.000 |
| 11/04/2022 | 88,32 | 89,48 | 86,18 | 86,63 | -1,20% | 3,74% | 14.381.000 |
| 08/04/2022 | 86,64 | 87,84 | 86,26 | 87,68 | +1,01% | 1,82% | 11.409.300 |
| 07/04/2022 | 85,75 | 87,11 | 84,96 | 86,80 | +2,15% | 2,51% | 13.104.300 |
| 06/04/2022 | 84,36 | 85,56 | 84,12 | 84,97 | +1,49% | 1,71% | 13.924.300 |
| 05/04/2022 | 83,66 | 85,43 | 83,51 | 83,72 | +0,28% | 2,30% | 12.040.900 |
| 04/04/2022 | 83,50 | 83,89 | 82,73 | 83,49 | -0,04% | 1,39% | 9.039.600 |